 | • レポートコード：MRC2-11QY01109 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は蠕虫感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（ベンズイミダゾール、ピランテル、ピペラジンクエン酸塩、その他）市場規模、用途別（ヒト蟯虫、無鉤条虫、ヒトカイチュウ、鞭虫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別蠕虫感染症治療薬の競争状況、市場シェア ・世界の蠕虫感染症治療薬市場：種類別市場規模 2015年-2020年（ベンズイミダゾール、ピランテル、ピペラジンクエン酸塩、その他） ・世界の蠕虫感染症治療薬市場：種類別市場規模予測 2021年-2026年（ベンズイミダゾール、ピランテル、ピペラジンクエン酸塩、その他） ・世界の蠕虫感染症治療薬市場：用途別市場規模 2015年-2020年（ヒト蟯虫、無鉤条虫、ヒトカイチュウ、鞭虫、その他） ・世界の蠕虫感染症治療薬市場：用途別市場規模予測 2021年-2026年（ヒト蟯虫、無鉤条虫、ヒトカイチュウ、鞭虫、その他） ・北米の蠕虫感染症治療薬市場分析：米国、カナダ ・ヨーロッパの蠕虫感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの蠕虫感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の蠕虫感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの蠕虫感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Neural Analytics, Inc.、M3 Biotechnology, Inc.、Cerevance、Mitochon Pharmaceuticals, Inc.、Peptilogics、Farmoquimica S/A、biOasis Technologies, Inc.、HCA Healthcare, Inc.、Alzeca Biosciences, Inc.、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Helminthic Infestations Therapeutics Market
The global Helminthic Infestations Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Helminthic Infestations Therapeutics Scope and Market Size
Helminthic Infestations Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Helminthic Infestations Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Helminthic Infestations Therapeutics market is segmented into
Benzimidazole
Pyrantel
Piperazine Citrate
Others
Segment by Application, the Helminthic Infestations Therapeutics market is segmented into
Enterobius vermicularis
Taenia saginata
Ascaris lumbricoides
Trichuris trichiura
Others
Regional and Country-level Analysis
The Helminthic Infestations Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Helminthic Infestations Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Helminthic Infestations Therapeutics Market Share Analysis
Helminthic Infestations Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Helminthic Infestations Therapeutics business, the date to enter into the Helminthic Infestations Therapeutics market, Helminthic Infestations Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Neural Analytics, Inc.
M3 Biotechnology, Inc.
Cerevance
Mitochon Pharmaceuticals, Inc.
Peptilogics
Farmoquimica S/A
biOasis Technologies, Inc.
HCA Healthcare, Inc.
Alzeca Biosciences, Inc.
Johnson & Johnson
1 Study Coverage
1.1 Helminthic Infestations Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Helminthic Infestations Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type
1.4.2 Benzimidazole
1.4.3 Pyrantel
1.4.4 Piperazine Citrate
1.4.5 Others
1.5 Market by Application
1.5.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Application
1.5.2 Enterobius vermicularis
1.5.3 Taenia saginata
1.5.4 Ascaris lumbricoides
1.5.5 Trichuris trichiura
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Helminthic Infestations Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Helminthic Infestations Therapeutics Revenue 2015-2026
2.1.2 Global Helminthic Infestations Therapeutics Sales 2015-2026
2.2 Global Helminthic Infestations Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Helminthic Infestations Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Helminthic Infestations Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Helminthic Infestations Therapeutics Competitor Landscape by Players
3.1 Helminthic Infestations Therapeutics Sales by Manufacturers
3.1.1 Helminthic Infestations Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Helminthic Infestations Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Helminthic Infestations Therapeutics Revenue by Manufacturers
3.2.1 Helminthic Infestations Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Helminthic Infestations Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2019
3.2.5 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Helminthic Infestations Therapeutics Price by Manufacturers
3.4 Helminthic Infestations Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Helminthic Infestations Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Helminthic Infestations Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Helminthic Infestations Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Helminthic Infestations Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Helminthic Infestations Therapeutics Sales by Type (2015-2020)
4.1.2 Global Helminthic Infestations Therapeutics Revenue by Type (2015-2020)
4.1.3 Helminthic Infestations Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Helminthic Infestations Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Helminthic Infestations Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Helminthic Infestations Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Helminthic Infestations Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Helminthic Infestations Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Helminthic Infestations Therapeutics Sales by Application (2015-2020)
5.1.2 Global Helminthic Infestations Therapeutics Revenue by Application (2015-2020)
5.1.3 Helminthic Infestations Therapeutics Price by Application (2015-2020)
5.2 Helminthic Infestations Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Helminthic Infestations Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Helminthic Infestations Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Helminthic Infestations Therapeutics by Country
6.1.1 North America Helminthic Infestations Therapeutics Sales by Country
6.1.2 North America Helminthic Infestations Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Helminthic Infestations Therapeutics Market Facts & Figures by Type
6.3 North America Helminthic Infestations Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Helminthic Infestations Therapeutics by Country
7.1.1 Europe Helminthic Infestations Therapeutics Sales by Country
7.1.2 Europe Helminthic Infestations Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Helminthic Infestations Therapeutics Market Facts & Figures by Type
7.3 Europe Helminthic Infestations Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Helminthic Infestations Therapeutics by Region
8.1.1 Asia Pacific Helminthic Infestations Therapeutics Sales by Region
8.1.2 Asia Pacific Helminthic Infestations Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Helminthic Infestations Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Helminthic Infestations Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Helminthic Infestations Therapeutics by Country
9.1.1 Latin America Helminthic Infestations Therapeutics Sales by Country
9.1.2 Latin America Helminthic Infestations Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Helminthic Infestations Therapeutics Market Facts & Figures by Type
9.3 Central & South America Helminthic Infestations Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Helminthic Infestations Therapeutics by Country
10.1.1 Middle East and Africa Helminthic Infestations Therapeutics Sales by Country
10.1.2 Middle East and Africa Helminthic Infestations Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Helminthic Infestations Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Helminthic Infestations Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Neural Analytics, Inc.
11.1.1 Neural Analytics, Inc. Corporation Information
11.1.2 Neural Analytics, Inc. Description and Business Overview
11.1.3 Neural Analytics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Products Offered
11.1.5 Neural Analytics, Inc. Related Developments
11.2 M3 Biotechnology, Inc.
11.2.1 M3 Biotechnology, Inc. Corporation Information
11.2.2 M3 Biotechnology, Inc. Description and Business Overview
11.2.3 M3 Biotechnology, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Products Offered
11.2.5 M3 Biotechnology, Inc. Related Developments
11.3 Cerevance
11.3.1 Cerevance Corporation Information
11.3.2 Cerevance Description and Business Overview
11.3.3 Cerevance Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cerevance Helminthic Infestations Therapeutics Products Offered
11.3.5 Cerevance Related Developments
11.4 Mitochon Pharmaceuticals, Inc.
11.4.1 Mitochon Pharmaceuticals, Inc. Corporation Information
11.4.2 Mitochon Pharmaceuticals, Inc. Description and Business Overview
11.4.3 Mitochon Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Products Offered
11.4.5 Mitochon Pharmaceuticals, Inc. Related Developments
11.5 Peptilogics
11.5.1 Peptilogics Corporation Information
11.5.2 Peptilogics Description and Business Overview
11.5.3 Peptilogics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Peptilogics Helminthic Infestations Therapeutics Products Offered
11.5.5 Peptilogics Related Developments
11.6 Farmoquimica S/A
11.6.1 Farmoquimica S/A Corporation Information
11.6.2 Farmoquimica S/A Description and Business Overview
11.6.3 Farmoquimica S/A Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Products Offered
11.6.5 Farmoquimica S/A Related Developments
11.7 biOasis Technologies, Inc.
11.7.1 biOasis Technologies, Inc. Corporation Information
11.7.2 biOasis Technologies, Inc. Description and Business Overview
11.7.3 biOasis Technologies, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Products Offered
11.7.5 biOasis Technologies, Inc. Related Developments
11.8 HCA Healthcare, Inc.
11.8.1 HCA Healthcare, Inc. Corporation Information
11.8.2 HCA Healthcare, Inc. Description and Business Overview
11.8.3 HCA Healthcare, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Products Offered
11.8.5 HCA Healthcare, Inc. Related Developments
11.9 Alzeca Biosciences, Inc.
11.9.1 Alzeca Biosciences, Inc. Corporation Information
11.9.2 Alzeca Biosciences, Inc. Description and Business Overview
11.9.3 Alzeca Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Products Offered
11.9.5 Alzeca Biosciences, Inc. Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Neural Analytics, Inc.
11.1.1 Neural Analytics, Inc. Corporation Information
11.1.2 Neural Analytics, Inc. Description and Business Overview
11.1.3 Neural Analytics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Products Offered
11.1.5 Neural Analytics, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Helminthic Infestations Therapeutics Market Estimates and Projections by Region
12.1.1 Global Helminthic Infestations Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Helminthic Infestations Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Helminthic Infestations Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Helminthic Infestations Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Helminthic Infestations Therapeutics Market Segments
Table 2. Ranking of Global Top Helminthic Infestations Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Benzimidazole
Table 5. Major Manufacturers of Pyrantel
Table 6. Major Manufacturers of Piperazine Citrate
Table 7. Major Manufacturers of Others
Table 8. Global Helminthic Infestations Therapeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Helminthic Infestations Therapeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Helminthic Infestations Therapeutics Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Helminthic Infestations Therapeutics Sales Market Share by Regions (2015-2020)
Table 12. Global Helminthic Infestations Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Helminthic Infestations Therapeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Helminthic Infestations Therapeutics Sales Share by Manufacturers (2015-2020)
Table 15. Global Helminthic Infestations Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Helminthic Infestations Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Helminthic Infestations Therapeutics as of 2019)
Table 17. Helminthic Infestations Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Helminthic Infestations Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Helminthic Infestations Therapeutics Price (2015-2020) (USD/Pcs)
Table 20. Helminthic Infestations Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Helminthic Infestations Therapeutics Product Type
Table 22. Date of International Manufacturers Enter into Helminthic Infestations Therapeutics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 25. Global Helminthic Infestations Therapeutics Sales Share by Type (2015-2020)
Table 26. Global Helminthic Infestations Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Helminthic Infestations Therapeutics Revenue Share by Type (2015-2020)
Table 28. Helminthic Infestations Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 30. Global Helminthic Infestations Therapeutics Sales Share by Application (2015-2020)
Table 31. North America Helminthic Infestations Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 32. North America Helminthic Infestations Therapeutics Sales Market Share by Country (2015-2020)
Table 33. North America Helminthic Infestations Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Helminthic Infestations Therapeutics Revenue Market Share by Country (2015-2020)
Table 35. North America Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 36. North America Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Table 37. North America Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 38. North America Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Table 39. Europe Helminthic Infestations Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Helminthic Infestations Therapeutics Sales Market Share by Country (2015-2020)
Table 41. Europe Helminthic Infestations Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Helminthic Infestations Therapeutics Revenue Market Share by Country (2015-2020)
Table 43. Europe Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Table 45. Europe Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Helminthic Infestations Therapeutics Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Helminthic Infestations Therapeutics Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Helminthic Infestations Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Helminthic Infestations Therapeutics Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Table 55. Latin America Helminthic Infestations Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Helminthic Infestations Therapeutics Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Helminthic Infestations Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Helminthic Infestations Therapeutics Revenue Market Share by Country (2015-2020)
Table 59. Latin America Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Latin America Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Helminthic Infestations Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Helminthic Infestations Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Table 71. Neural Analytics, Inc. Corporation Information
Table 72. Neural Analytics, Inc. Description and Major Businesses
Table 73. Neural Analytics, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Neural Analytics, Inc. Product
Table 75. Neural Analytics, Inc. Recent Development
Table 76. M3 Biotechnology, Inc. Corporation Information
Table 77. M3 Biotechnology, Inc. Description and Major Businesses
Table 78. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. M3 Biotechnology, Inc. Product
Table 80. M3 Biotechnology, Inc. Recent Development
Table 81. Cerevance Corporation Information
Table 82. Cerevance Description and Major Businesses
Table 83. Cerevance Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Cerevance Product
Table 85. Cerevance Recent Development
Table 86. Mitochon Pharmaceuticals, Inc. Corporation Information
Table 87. Mitochon Pharmaceuticals, Inc. Description and Major Businesses
Table 88. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Mitochon Pharmaceuticals, Inc. Product
Table 90. Mitochon Pharmaceuticals, Inc. Recent Development
Table 91. Peptilogics Corporation Information
Table 92. Peptilogics Description and Major Businesses
Table 93. Peptilogics Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Peptilogics Product
Table 95. Peptilogics Recent Development
Table 96. Farmoquimica S/A Corporation Information
Table 97. Farmoquimica S/A Description and Major Businesses
Table 98. Farmoquimica S/A Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Farmoquimica S/A Product
Table 100. Farmoquimica S/A Recent Development
Table 101. biOasis Technologies, Inc. Corporation Information
Table 102. biOasis Technologies, Inc. Description and Major Businesses
Table 103. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. biOasis Technologies, Inc. Product
Table 105. biOasis Technologies, Inc. Recent Development
Table 106. HCA Healthcare, Inc. Corporation Information
Table 107. HCA Healthcare, Inc. Description and Major Businesses
Table 108. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. HCA Healthcare, Inc. Product
Table 110. HCA Healthcare, Inc. Recent Development
Table 111. Alzeca Biosciences, Inc. Corporation Information
Table 112. Alzeca Biosciences, Inc. Description and Major Businesses
Table 113. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Alzeca Biosciences, Inc. Product
Table 115. Alzeca Biosciences, Inc. Recent Development
Table 116. Johnson & Johnson Corporation Information
Table 117. Johnson & Johnson Description and Major Businesses
Table 118. Johnson & Johnson Helminthic Infestations Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Johnson & Johnson Product
Table 120. Johnson & Johnson Recent Development
Table 121. Global Helminthic Infestations Therapeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 122. Global Helminthic Infestations Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Helminthic Infestations Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Helminthic Infestations Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Helminthic Infestations Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. North America: Helminthic Infestations Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Helminthic Infestations Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Europe: Helminthic Infestations Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Helminthic Infestations Therapeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 130. Asia Pacific: Helminthic Infestations Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Helminthic Infestations Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. Latin America: Helminthic Infestations Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Helminthic Infestations Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Middle East and Africa: Helminthic Infestations Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Helminthic Infestations Therapeutics Players
Table 139. Helminthic Infestations Therapeutics Customers List
Table 140. Helminthic Infestations Therapeutics Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Helminthic Infestations Therapeutics Product Picture
Figure 2. Global Helminthic Infestations Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Benzimidazole Product Picture
Figure 4. Pyrantel Product Picture
Figure 5. Piperazine Citrate Product Picture
Figure 6. Others Product Picture
Figure 7. Global Helminthic Infestations Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 8. Enterobius vermicularis
Figure 9. Taenia saginata
Figure 10. Ascaris lumbricoides
Figure 11. Trichuris trichiura
Figure 12. Others
Figure 13. Helminthic Infestations Therapeutics Report Years Considered
Figure 14. Global Helminthic Infestations Therapeutics Market Size 2015-2026 (US$ Million)
Figure 15. Global Helminthic Infestations Therapeutics Sales 2015-2026 (K Pcs)
Figure 16. Global Helminthic Infestations Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Helminthic Infestations Therapeutics Sales Market Share by Region (2015-2020)
Figure 18. Global Helminthic Infestations Therapeutics Sales Market Share by Region in 2019
Figure 19. Global Helminthic Infestations Therapeutics Revenue Market Share by Region (2015-2020)
Figure 20. Global Helminthic Infestations Therapeutics Revenue Market Share by Region in 2019
Figure 21. Global Helminthic Infestations Therapeutics Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Helminthic Infestations Therapeutics Revenue in 2019
Figure 23. Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Helminthic Infestations Therapeutics Sales Market Share by Type (2015-2020)
Figure 25. Global Helminthic Infestations Therapeutics Sales Market Share by Type in 2019
Figure 26. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2015-2020)
Figure 27. Global Helminthic Infestations Therapeutics Revenue Market Share by Type in 2019
Figure 28. Global Helminthic Infestations Therapeutics Market Share by Price Range (2015-2020)
Figure 29. Global Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
Figure 30. Global Helminthic Infestations Therapeutics Sales Market Share by Application in 2019
Figure 31. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2015-2020)
Figure 32. Global Helminthic Infestations Therapeutics Revenue Market Share by Application in 2019
Figure 33. North America Helminthic Infestations Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Helminthic Infestations Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Helminthic Infestations Therapeutics Sales Market Share by Country in 2019
Figure 36. North America Helminthic Infestations Therapeutics Revenue Market Share by Country in 2019
Figure 37. U.S. Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Helminthic Infestations Therapeutics Market Share by Type in 2019
Figure 42. North America Helminthic Infestations Therapeutics Market Share by Application in 2019
Figure 43. Europe Helminthic Infestations Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Helminthic Infestations Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Helminthic Infestations Therapeutics Sales Market Share by Country in 2019
Figure 46. Europe Helminthic Infestations Therapeutics Revenue Market Share by Country in 2019
Figure 47. Germany Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Helminthic Infestations Therapeutics Market Share by Type in 2019
Figure 58. Europe Helminthic Infestations Therapeutics Market Share by Application in 2019
Figure 59. Asia Pacific Helminthic Infestations Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Helminthic Infestations Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Helminthic Infestations Therapeutics Sales Market Share by Region in 2019
Figure 62. Asia Pacific Helminthic Infestations Therapeutics Revenue Market Share by Region in 2019
Figure 63. China Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Helminthic Infestations Therapeutics Market Share by Type in 2019
Figure 86. Asia Pacific Helminthic Infestations Therapeutics Market Share by Application in 2019
Figure 87. Latin America Helminthic Infestations Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Helminthic Infestations Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Helminthic Infestations Therapeutics Sales Market Share by Country in 2019
Figure 90. Latin America Helminthic Infestations Therapeutics Revenue Market Share by Country in 2019
Figure 91. Mexico Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Helminthic Infestations Therapeutics Market Share by Type in 2019
Figure 98. Latin America Helminthic Infestations Therapeutics Market Share by Application in 2019
Figure 99. Middle East and Africa Helminthic Infestations Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Helminthic Infestations Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Country in 2019
Figure 103. Turkey Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Helminthic Infestations Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Helminthic Infestations Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Helminthic Infestations Therapeutics Market Share by Type in 2019
Figure 110. Middle East and Africa Helminthic Infestations Therapeutics Market Share by Application in 2019
Figure 111. North America Helminthic Infestations Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Helminthic Infestations Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Helminthic Infestations Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Helminthic Infestations Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Helminthic Infestations Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Helminthic Infestations Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Helminthic Infestations Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Helminthic Infestations Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Helminthic Infestations Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Helminthic Infestations Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
血友病A・B治療材料の世界市場（～2026年） Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. Novel treatments for people suffering from hemophilia and other different bleeding problems h…- 犬インフルエンザ治療薬の世界市場（～2026年） Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus. Market Analysis and Insights: Global Canine Flu Therapeu…
- 全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…
- 痛風治療薬の世界市場（～2026年） Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to …
- 淋病治療薬の世界市場（～2026年） Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep…